+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of dyslipidemia and borderline dyslipidemia and other risk factors of coronary heart disease in residents from Beijing communities

Prevalence of dyslipidemia and borderline dyslipidemia and other risk factors of coronary heart disease in residents from Beijing communities

Zhonghua Xin Xue Guan Bing Za Zhi 38(2): 175-180

To investigate the prevalence of dyslipidemia and borderline dyslipidemia and other coronary heart disease (CHD) risk factors in residents from Beijing communities. Resident samples were selected by random cluster multistage method. Serum lipid level and CHD factors were obtained through questionnaire, physical examination and biochemical analysis during June 2007 to August 2007 from 10 054 residents. Age- and sex-adjusted standardized prevalence of hypercholesterolemia, high low-density lipoprotein cholesterolemia, low high-density lipoprotein cholesterolemia, and triglyceridemia were 9.3%, 2.56%, 18.79% and 16.84%, respectively. Incidence of borderline hypercholesterolemia was 23.96%. Incidence of dyslipidemia and borderline dyslipidemia was 31.23% and 23.30% respectively, 71.17% residents have at least 1 CHD major risk factor and 20.23% residents were in borderline CHD risks. Prevalence of hypertension, diabetes, smoking and obese was 41.57%, 11.08%, 35.81% and 22.89%, respectively. The odds ratio for dyslipidemia (95% confidence interval) in residents having 1 borderline CHD risk factor (RF), 2 RF, and 3 RF versus none RF was 1.668, (95%CI: 1.319 - 2.110), 2.537 (95%CI: 1.989 - 3.235), and 3.203 (95%CI: 2.007 - 5.114). The prevalence of dyslipidemia of residents from Beijing communities is higher the average level of China (25.1%). Over 1 out of 5 residents were in increased risk for borderline dyslipidemia or CHD risks. Intensive control of dyslipidemia and CHD risk factors are warranted in Beijing residents.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 055157396

Download citation: RISBibTeXText

PMID: 20398568

Related references

Prevalence of dyslipidemia and borderline dyslipidemia in aging residents from Beijing communities. Zhonghua Yi Xue Za Zhi 93(46): 3675-3679, 2014

Epidemiologic characteristics of major risk factors of coronary heart disease in residents from Beijing communities in different age groups. Zhonghua Yi Xue Za Zhi 90(8): 529-534, 2010

Prevalence of dyslipidemia and its association with other coronary artery disease risk factors among urban population in Southeast of Iran: results of the Kerman coronary artery disease risk factors study (KERCADRS). Journal of Diabetes and Metabolic Disorders 15: 49, 2016

Prevalence of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family medicine framework--results of LIPIDOGRAM 2005--a nationwide epidemiological study. Dyslipidemia in Poland--ineffective treatment. Przeglad Lekarski 65(12): 834-837, 2008

Study on the prevalence of dyslipidemia and associated dietary risk factors among adults in Shunyi District of Beijing. Wei Sheng Yan Jiu 42(4): 565-570, 2013

The estimated risk for coronary heart disease and prevalence of dyslipidemia among workers of information technology industries in Taiwan. Clinica Chimica Acta; International Journal of Clinical Chemistry 412(7-8): 569-573, 2011

Factors associated with dyslipidemia awareness among residents in Beijing results from CCEIP. Zhongguo Shiyong Neike Zazhi: 1, 38-40, 2010

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New England Journal of Medicine 317(20): 1237-1245, 1987

Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study. Preventive Cardiology 12(2): 65-71, 2009

Prevalence of dyslipidemia and factors affecting dyslipidemia in young adults with type 1 diabetes: evaluation of statin prescribing. Journal of Pediatric Endocrinology and Metabolism 32(4): 327-334, 2019

Postprandial dyslipidemia: a risk factor for coronary heart disease. Annals of Nutrition & Metabolism 42(1): 1-11, 1998

Insulin resistance and dyslipidemia Implications for coronary heart disease risk. Reaven, G M , Laws, A Contemporary Endocrinology; Insulin resistance: The metabolic syndrome X 267-280, 1999

Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons. HIV Clinical Trials 5(6): 416-433, 2005

Combining effect of dyslipidemia with other coronary risk factors on the prognosis of patients with coronary artery disease. Japanese Circulation Journal 60(7): 520-521, 1996

Dyslipidemia and Risk of Coronary Heart Disease: Role of Lifestyle Approaches for Its Management. American Journal of Lifestyle Medicine 3(4): 257-273, 2009